Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study
Dan Wang,Ruifang Li,Juan Wang,Qunqun Jiang,Chang Gao,Juan Yang,Lintong Ge,Qing Hu
DOI: https://doi.org/10.1186/s12879-020-05242-w
IF: 3.7
2020-07-16
BMC Infectious Diseases
Abstract:Abstract Background Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan and has quickly spread across the world. The mortality rate in critically ill patients with COVID-19 is high. This study analyzed clinical and biochemical parameters between mild and severe patients, helping to identify severe or critical patients early. Methods In this single center, cross-sectional study, 143 patients were included and divided to mild/moderate and sever/critical groups. Correlation between the disease criticality and clinical features and peripheral blood biochemical markers was analyzed. Cut-off values for critically ill patients were speculated through the ROC curve. Results Significantly, disease severity was associated with age ( r = 0.458, P < 0.001), comorbidities ( r = 0.445, P < 0.001), white cell count ( r = 0.229, P = 0.006), neutrophil count ( r = 0.238, P = 0.004), lymphocyte count ( r = − 0.295, P < 0.001), albumin ( r = − 0.603, P < 0.001), high-density lipoprotein cholesterol ( r = − 0.362, P < 0.001), serum potassium ( r = − 0.237, P = 0.004), plasma glucose ( r = 0.383, P < 0.001), total bilirubin ( r = 0.340, P < 0.001), serum amyloid A ( r = 0.58, P < 0.001), procalcitonin ( r = 0.345, P < 0.001), C-reactive protein ( r = 0.477, P < 0.001), lactate dehydrogenase ( r = 0.548, P < 0.001), aspartate aminotransferase ( r = 0.342, P < 0.001), alanine aminotransferase ( r = 0.264, P = 0.001), erythrocyte sedimentation rate ( r = 0.284, P = 0.001) and D-dimer ( r = 0.477, P < 0.001) . Conclusions With the following parameters such as age > 52 years, C-reactive protein > 64.79 mg/L, lactate dehydrogenase > 245 U/L, D-dimer > 0.96 μg/mL, serum amyloid A > 100.02 mg/L, or albumin < 36 g/L, the progress of COVID-19 to critical stage should be closely observed and possibly prevented. Lymphocyte count, serum potassium, high-density lipoprotein cholesterol and procalcitonin may also be a prognostic indicator.
infectious diseases